IDH2 and acute myeloid leukemia: In vitro cellular models of IDH mutations, either human or murine, highlight a significant increase in DNA methylation in IDH1/2 mutant-expressing cells [24], in keeping with the hypermethylation signature observed in AML patients [24], and is supported by experimental data showing impaired myeloid differentiation [24,35,36] (Supplementary Materials).